Livermore

DC Funds, LP

SEC CIK
0001869028

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC

Positions
3
0 vs. Q1 2026
Total value
$1.25M
−$232.56K (−15.7%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

DC Funds, LP holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
TCRXTSCAN THERAPEUTICS INCCOM630,000$617.46K49.27%00.0%UnchangedView
VACCITECH PLC91864C107ADS642,204$423.86K33.82%00.0%Unchanged–
HOWLWEREWOLF THERAPEUTICS INCCOM589,102$212.02K16.92%00.0%UnchangedView

13F filings by quarter

DC Funds, LP 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 14, 20263$1.25Mvs. Q1 2026SEC
Q1 2026May 14, 20263$1.49Mvs. Q4 2025SEC
Q4 2025Feb 13, 20263$1.45Mvs. Q3 2025SEC
Q3 2025Nov 10, 20253$3.11Mvs. Q2 2025SEC
Q2 2025Aug 14, 20253$2.15Mvs. Q1 2025SEC
Q1 2025May 14, 20253$2.07Mvs. Q4 2024SEC
Q4 2024Feb 14, 20253$3.56Mvs. Q3 2024SEC
Q3 2024Nov 14, 20243$5.15Mvs. Q2 2024SEC
Q2 2024Aug 13, 20243$6.02Mvs. Q1 2024SEC
Q1 2024May 14, 20243$10.35Mvs. Q4 2023SEC
Q4 2023Feb 13, 20243$8.32Mvs. Q3 2023SEC
Q3 2023Nov 14, 20233$4.86Mvs. Q2 2023SEC
Q2 2023Aug 10, 20233$4.69Mvs. Q1 2023SEC
Q1 2023May 15, 20233$4.29Mvs. Q4 2022SEC
Q4 2022Feb 14, 20233$3.69Mvs. Q3 2022SEC
Q3 2022Nov 14, 20223$6.63Mvs. Q2 2022SEC
Q2 2022Aug 12, 20223$7.25Mvs. Q1 2022SEC
Q1 2022May 13, 20223$7.7Mvs. Q4 2021SEC
Q4 2021Feb 11, 20223$16.89Mvs. Q3 2021SEC
Q3 2021Nov 12, 20213$25.47Mvs. Q2 2021SEC
Q2 2021Aug 23, 2021Amended2$21.05M–SEC